Volume 8, Issue 2

Lung Transplant and CRC Screening

In this issue:

Screening to avoid the morbidity and mortality of colorectal cancer (CRC) in patients with CF, with the incidence of CRC rising, has become an increasingly important challenge, particularly among lung transplant patients.  But how and when should patients be screened? With colonoscopy or non-invasive FIT? Before or after transplant?  Are there patients who should not be screened, and why?

In this issue, Dr. Denis Hadjiliadis from the Perelman School of Medicine at the University of Pennsylvania discusses the clinical aspects of screening patients with CF to prevent CRC.

Learning objectives:

  • Describe strategies for colorectal cancer screening in patients with CF prior to lung transplant.
  • Describe strategies for colorectal cancer screening in patients with CF after lung transplant.

Author:

Denis Hadjiliadis, MD
Denis Hadjiliadis, MD
Paul F Harron, Jr. Associate Professor of Medicine
Division of Pulmonary, Allergy and Critical Care
Program Director, Adult Cystic Fibrosis Center
Perelman School of Medicine, University of Pennsylvania

Program Directors:

Peter J. Mogayzel, Jr., MD, PhD
Professor of Pediatrics
Director, Cystic Fibrosis Center
Johns Hopkins University School of Medicine
Baltimore, MD

Noah Lechtzin, MD, MHA
Director, Adult Cystic Fibrosis Program
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD

Suzanne Sullivan, RN, BSN
Senior Clinical Nurse
The Johns Hopkins University
Baltimore, MD

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: October 26, 2018
Expiration date: October 25, 2020

Sign-In

Not a subscriber? Start here!